Your browser doesn't support javascript.
loading
Proof-of-concept randomized controlled trial of single-session nitrous oxide treatment for refractory bipolar depression: Focus on cerebrovascular target engagement.
Kim, William S H; Dimick, Mikaela K; Omrin, Danielle; Mitchell, Rachel H B; Riegert, Daniel; Levitt, Anthony; Schaffer, Ayal; Belo, Susan; Iazzetta, John; Detzler, Garfield; Choi, Mabel; Choi, Stephen; Herrmann, Nathan; McIntyre, Roger S; MacIntosh, Bradley J; Orser, Beverley A; Goldstein, Benjamin I.
Afiliação
  • Kim WSH; Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.
  • Dimick MK; Hurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, Ontario, Canada.
  • Omrin D; Centre for Youth Bipolar Disorder, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
  • Mitchell RHB; Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
  • Riegert D; Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada.
  • Levitt A; Centre for Youth Bipolar Disorder, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
  • Schaffer A; Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
  • Belo S; Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
  • Iazzetta J; Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada.
  • Detzler G; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.
  • Choi M; Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
  • Choi S; Department of Anesthesiology and Pain Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Herrmann N; Hurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, Ontario, Canada.
  • McIntyre RS; Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
  • MacIntosh BJ; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.
  • Orser BA; Hurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, Ontario, Canada.
  • Goldstein BI; Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
Bipolar Disord ; 25(3): 221-232, 2023 05.
Article em En | MEDLINE | ID: mdl-36579458
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtorno Bipolar / Transtorno Depressivo Resistente a Tratamento Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Humans Idioma: En Revista: Bipolar Disord Assunto da revista: PSIQUIATRIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Canadá
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtorno Bipolar / Transtorno Depressivo Resistente a Tratamento Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Humans Idioma: En Revista: Bipolar Disord Assunto da revista: PSIQUIATRIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Canadá